Johnson & Johnson (JNJ) Free Cash Flow (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Free Cash Flow came in at $1.5 billion in Q1 2026, down 56.64% year-on-year from $3.4 billion in Q1 2025, and down 73.23% quarter-over-quarter from $5.5 billion in Q4 2025.

Johnson & Johnson (JNJ) Free Cash Flow (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Free Cash Flow across 18 years of filings, most recently posting $1.5 billion for Q1 2026.

  • Free Cash Flow for Q1 2026 came in at $1.5 billion, down 56.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.8 billion (down 12.7% YoY), and the FY2025 annual result was $19.7 billion, down 0.73% from the prior year.
  • Free Cash Flow came in at $1.5 billion for Q1 2026 at Johnson & Johnson, down from $5.5 billion in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $8.0 billion in Q3 2025 to a low of $1.5 billion in Q1 2026.
  • The 5-year median for Free Cash Flow is $3.4 billion (2025), against an average of $4.3 billion.
  • Across the five-year window, Free Cash Flow surged 259.75% in 2023 and sank 56.64% in 2026, its largest moves.
  • Johnson & Johnson's Free Cash Flow stood at $3.4 billion in 2022, then jumped by 86.06% to $6.3 billion in 2023, then declined by 14.39% to $5.4 billion in 2024, then gained by 1.88% to $5.5 billion in 2025, then tumbled by 73.23% to $1.5 billion in 2026.
  • The last three Free Cash Flow figures came in at $1.5 billion (Q1 2026), $5.5 billion (Q4 2025), and $8.0 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 2.12 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 3.01 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 1.47 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 3.56 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 2.93 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 1.48 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 2.43 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 2.18 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 757.00 Mn
10 Novartis Ag 108.28 Bn 107.60 Bn - 346.00 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 1.47 Bn
Mar 29, 2026 1.47 Bn
Dec 28, 2025 5.47 Bn
Dec 28, 2025 5.47 Bn
Sep 28, 2025 8.01 Bn
Sep 28, 2025 8.01 Bn
Jun 29, 2025 2.84 Bn
Jun 29, 2025 2.84 Bn
Mar 30, 2025 3.38 Bn
Mar 30, 2025 3.38 Bn
Dec 29, 2024 5.37 Bn
Dec 29, 2024 5.37 Bn
Sep 29, 2024 6.96 Bn
Sep 29, 2024 6.96 Bn
Jun 30, 2024 4.66 Bn
Jun 30, 2024 4.66 Bn
Mar 31, 2024 2.85 Bn
Mar 31, 2024 2.85 Bn
Dec 31, 2023 6.27 Bn
Dec 31, 2023 6.27 Bn